Data / Form D filings / StrideBio, Inc.
StrideBio, Inc.: Form D filings
StrideBio, Inc., a biotechnology company in Durham, NC, filed 3 Form D notices with the SEC between 2017 and 2021. The latest, on March 26, 2021, reports $48.9 million sold of a $81.5 million offering to 17 investors.
Find out what StrideBio, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 5 LABORATORY DRIVE, SUITE 1200, Durham, NC, 27709
- Phone
- (984) 213-7300
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1708278
The full lists. Form D filings in North Carolina: 984 rows, $49.20, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 26, 2021 | New notice | $81,529,870 | $48,917,942 | $32,611,928 | 17 | Mar 11, 2021 | sec.gov |
| Jun 18, 2018 | New notice | $15,839,065 | $7,739,081 | $8,099,984 | 12 | Jun 12, 2018 | sec.gov |
| Jun 5, 2017 | New notice | $1,000,000 | $1,000,000 | $0 | 3 | May 24, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Sapan Shah | Executive Officer, Director | |
| Maritza McIntyre | Executive Officer | |
| William Monteith | Executive Officer | |
| Robert Hughes | Executive Officer | |
| Shaan Gandhi | Director | |
| Stewart Parker | Director | |
| Clay Thorp | Director | |
| Erica Whittaker | Director | |
| Michael Martin | Director | |
| Aravind Asokan | Director | |
| Karen Hong | Director |
Other biotechnology companies in North Carolina that filed recently
- Toggle Bio $200,000 · Oct 6, 2026
- Swift Cardiovascular, Inc. $810,000 · Sep 24, 2026
- Aclarity Genomics, Inc. $4.6 million · Sep 2, 2026
- Aer Therapeutics, Inc. $3 million · Aug 19, 2026
Every Form D from the week of Mar 22, 2021 · All recent filings in North Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what StrideBio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.